EMA: Marinus Filing Up For An Opinion; Amylyx, GSK & Curium Due For Oral Explanations
The European Medicines Agency’s human medicines committee, the CHMP, is meeting this week to discuss the EU marketing applications for a number of products that have reached the late stages of the regulatory review cycle.